Explore evidence

757 patientsThe study involved 757 SCD patients aged 10 to 29 years at the Center de Recherche et de Lutte contre la Drépanocytose (CRLD) in Bamako, Mali.

Malidrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 9 observations

Sickle cell disease is associated with unacceptable morbidity and mortality rates in the absence of diagnosis and care.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

36.7 %Linkage-to-care for sickle cell disease newborns was effective for only 36.7% (22/60) within the first 6 months.

Malidrépanocytoseobserved first 6 monthsHAL · Unilimdocument of 103 observations

40,000 personsThe Sickle Pan-African Research Consortium (SPARCo) registry includes data from over 40,000 persons living with sickle cell disease in seven African countries.

Ghana · Mali · Nigeria · Ouganda · Tanzanie · Zambie · Zimbabwedrépanocytosepublished 2026Database : the journal of biological databases and curationeurope_pmc

58 %58% of mothers did not know the causes of sickle cell disease.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

2.5 %Iron deficiency was found in 19 SCD patients (2.5%) in a cross-sectional study of 757 SCD patients in Bamako, Mali.

Malidrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 9 observations

331 individualsThe study included 331 sickle cell disease and 379 control African American individuals.

Malidrépanocytosepublished 2015PeerJOpenAlexdocument of 9 observationsDOI 10.7717/peerj.799

68.4 %Iron deficiency was observed in 68.4% of SCD patients with the SC phenotype.

Malidrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 9 observations

12 %Au Mali, la fréquence du trait drépanocytaire est située autour de 12 %.

MalidrépanocytoseHAL · Unilimdocument of 202 observations

92.9 %The highest proportion of cerebral vasculopathy (92.9%) was observed in homozygous SCD patients.

Malicerebral vasculopathy · drépanocytosepublished 2013BloodOpenAlexdocument of 10 observations

95.22 %HemotypeSC® had a sensitivity of 95.22% to detect sickle cell disease carrier compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

18.3 %18.3% of mothers stated they would resort to self-medication in the event of discovered sickle cell disease.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

96.1 %SickleScan® had a sensitivity of 96.10% to detect sickle cell disease carrier compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

4 %In Côte d’Ivoire and its neighbouring countries (Ghana, Burkina Faso and Mali), the prevalence of sickle cell genetic traits is between 4% and 25%.

Burkina Faso · Ghana · MalidrépanocytoseHAL · Unilimdocument of 59 observations

13.9 %13.9% of mothers stated they would resort to a traditional practitioner in the event of discovered sickle cell disease.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

The prevalence of dyspnea and congestive heart failure was low and did not differ significantly between sickle cell disease patients and healthy controls in Cameroon, Mali, and Senegal.

Cameroun · Mali · Sénégaldrépanocytosepublished 2018Frontiers in MedicineOpenAlexdocument of 10 observationsDOI 10.3389/fmed.2018.00323

79.66 %HemotypeSC® had a positive predictive value (PPV) of 79.66% (95% CI: 69.39–89.93) to detect sickle cell disease.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

12 %Sickle cell disease prevalence in Mali is estimated at 12%.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations